Hyprvue Microscope

Hyper Vision Limited

Powered by Artificial Intelligence

The Hyprvue Microscope overlays AI-based information onto the present image of the sample in real-time, allowing AI to be seamlessly integrated into routine procedures.

The microscopic examination of tissue samples is critical for cancer diagnosis and staging, as well as guiding therapy. However, there is a lot of variation in these assessments, and many parts of the world do not have access to trained pathologists.

The Hyprvue Microscope is expected to break down obstacles by applying artificial intelligence (AI) to increase the accuracy and efficiency of cancer detection. An artificial intelligence-powered microscope that can detect tumor cells in histopathology slides has the potential to accelerate cancer diagnostic pathology procedures.

The goal is to enhance diagnosis accuracy and speed by combining AI with augmented reality, making artificial intelligence more helpful to researchers and doctors who care for patients.

Hyper Vision Limited

Hyper Vision Limited

Hyprvue Microscope

Notably, the Hyprvue Microscope can be retrofitted into current light microscopes in hospitals and clinics worldwide utilizing low-cost. It has readily available components and no requirement for complete digital slide representations of the tissue to be examined. Hyper Vision Limited is currently developing the Hyprvue Microscope with prototypes in the early stages of trials. We are aiming to release the technology commercially by early 2023.

Hyper Vision Limited is changing the future of healthcare by utilizing advances in augmented reality and artificial intelligence technology.
Contact Us

Rongchao Center,
6003 Yitian Road,
Futian District, Shenzhen, China. 518000